TWiV 334: In vino virus

April 26, 2015

Vitis viniferaHosts: Vincent RacanielloDickson DespommierAlan DoveRich Condit, and Kathy Spindler

The TWiVles talk about endogenous viruses in plants, sex and Ebolavirus transmission, an outbreak of canine influenza in the US, Dr. Oz, and doubling the NIH budget.

Click arrow to play
Download TWiV 334 (70 MB .mp3, 96 min)
Subscribe (free): iTunesRSSemail

This episode is sponsored by SciMed Solutions and ASM Education.

Links for this episode

Timestamps by Jennifer. Thank you!

Weekly Science Picks 1:17:05

Alan – NIH RFI: How do we fix this mess?
Rich – Editing embryos (PopSci, Prot Cell)
Kathy – Creative class presentations (one, two, three, four)
Dickson – The most tornadoes
Vincent – Apollo 13, 45 years later (Ars, IEEE, Farewell)

Listener Pick of the Week

Johnye – Rudolf and Leopold Blaschka

Send your virology questions and comments (email or mp3 file) to

Leave a Reply

Your email address will not be published. Required fields are marked *

4 comments on “TWiV 334: In vino virus

  1. Kevin Bonham Apr 26, 2015

    Alas, the audiommunity team is missing the AAI meeting, but I’ll be at ASM (also in New Orleans).

    Thanks Rich for getting the pronunciation right 😛

  2. I think I heard someone yawn when you listed all the responsible
    conduct or research topics in the special JMBE issue. Hopefully unintentional—it’s a
    good issue:
    (also includes some regular papers)

    I think the NIH RFI link should be this:

    According to this 2013 piece Dr. Oz ‘still performs operations there each Thursday’:
    Specter also wrote a blog post on the recent letter:

    No link for the wine spectator?

    Alan will be glad to know that we have a barley genome sequence:
    His jokes seemed more over the top than usual in the caulimovirus section—you should get a drumroll-cymbal crash sound.

    I hope you do another show with Jens Kuhn.

  3. Translational Research (PK) will be involved in the design and execution of in vivo PK/ADME studies and the evaluation of clinical pharmacokinetic data to support the development of Creative Animodel product candidates.
    Related link: